Search Tag: dexamethasone

ICU Management

2024 09 Jul

  Dexamethasone is a life-saving treatment for severe COVID-19, though patients exhibit varied responses to the therapy. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité – Universitätsmedizin Berlin have uncovered how this cortisone compound influences the impaired inflammatory response and which patients benefit...Read more

ICU Management

2022 20 Sep

Acute hypoxaemic respiratory failure (AHRF) is one of the main manifestations of severe COVID-19. The RECOVERY trial showed that dexamethasone 6 mg/d for ten days reduced 28-day mortality in patients with the most severe COVID-19. Another study described the benefit of high-dose dexamethasone in ARDS. However, Munch et al. found no difference between...Read more

ICU Management

2022 21 Mar

Obesity is highly prevalent in patients who are hospitalised with COVID-19. It is a widely recognised risk factor for severe COVID-19 infection with a greater risk for mortality compared with non-obese patients. With each 1 kg/m 2 increase in body mass index, the risk for severe infection increases by 9% and mortality by 6%.  While there are...Read more